Health
Preventing and Treating Cardiotoxicity in Patients With Breast Cancer Involves Aggressive Monitoring, Management Strategies – Cancer Network
Mandar Aras, MD, PhD, discussed the management and prevention of cardiotoxicity in patients receiving systemic therapy for breast cancer at the 38th Annual Miami…
Cardiac dysfunction is a prominent concern in patients receiving therapy for breast cancer, especially those with HER2-positive disease who may receive targeted therapies and have a history of prior anthracyclines exposure.
In a presentation at the 38th Annual Miami Breast Cancer Conference, hosted by Physicians Education Resource®, LLC, Mandar Aras, MD, PhD, of the University of California San Francisco, discussed best strategies for treating these patients, which includes consistent monitoring…
-
Business24 hours agoWhy is Alphabet stock worth less than Nvidia, Microsoft, Apple, and Amazon even though it is the most profitable S&P 500 company?
-
Noosa News23 hours ago‘Sunny, benign’ school holiday weather after morning showers in parts of Queensland
-
General18 hours agoDeveloper warns wind energy capacity may not be ready by WA coal deadline
-
General23 hours agoOlder Aussies back increased superannuation tax